[
    [
        {
            "time": "",
            "original_text": "智通港股公告精选︱(2.17)白云山子公司将迅速恢复生产磷酸氯喹片",
            "features": {
                "keywords": [
                    "白云山",
                    "子公司",
                    "磷酸氯喹片",
                    "恢复生产"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智通港股公告精选︱(2.17)白云山子公司将迅速恢复生产磷酸氯喹片",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白云山：子公司将在疫情期间恢复“磷酸氯喹片”生产",
            "features": {
                "keywords": [
                    "白云山",
                    "子公司",
                    "疫情期间",
                    "磷酸氯喹片",
                    "恢复生产"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白云山：子公司将在疫情期间恢复“磷酸氯喹片”生产",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白云山：子公司收到磷酸氯喹片《药品补充申请批件》，将迅速恢复该药品生产",
            "features": {
                "keywords": [
                    "白云山",
                    "子公司",
                    "磷酸氯喹片",
                    "药品补充申请批件",
                    "恢复生产"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白云山：子公司收到磷酸氯喹片《药品补充申请批件》，将迅速恢复该药品生产",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白云山(00874-HK)：子公司磷酸氯喹片获药品补充申请批件",
            "features": {
                "keywords": [
                    "白云山",
                    "子公司",
                    "磷酸氯喹片",
                    "药品补充申请批件"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白云山(00874-HK)：子公司磷酸氯喹片获药品补充申请批件",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "异动直击|获磷酸氯喹片药品补充申请批件，白云山高开3%",
            "features": {
                "keywords": [
                    "白云山",
                    "磷酸氯喹片",
                    "药品补充申请批件",
                    "高开"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "异动直击|获磷酸氯喹片药品补充申请批件，白云山高开3%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]